Vycor Medical Inc
VYCO· OTC
VYCOVycor Medical Inc
Filed Nov 13, 2020 · 10-Q · 44 days after period end · 0001493152-20-021209
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $275.93K | $322.88K | $456.21K | $379.07K |
| Net Income | -$198.29K | -$209.61K | -$152.18K | -$428.40K |
| EPS Diluted | -$0.01 | -$0.02 | -$0.01 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 13, 2020 · 44 d after period end
